Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: A secondary analysis of the HERO trial

Joel Gummer, Robert Trengove, Elaine M. Pascoe, Sunil V. Badve, Alan Cass, Philip Clarke, Stephen P. McDonald, Alicia T. Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A. Vergara, Carmel M. Hawley, David W. Johnson, John K. Olynyk, Paolo Ferrari, on behalf of the HERO Study Collaborative Group

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)
113 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: A secondary analysis of the HERO trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science